Considering the fourth quarter of 2022 earnings season the Major Pharmaceutical Preparations company lost money at $-0.42 per share, relative to the results of $-0.91 per share a year prior reporting period, In the prior reporting period the Cytomx Therapeutics Inc realized $-0.35 per share.

Cytomx Therapeutics Inc Suppliers

Cytomx Therapeutics Inc Income Statement, Balance sheets, Cash Flow Statement

For the fourth quarter of 2022 ACER increased a deficit per share of $-0.54 per share compare to $-0.30 a year before and grew deficit from $-0.31 per share from the prior quarter.

Revenues remained unchanged to $0.00 millions from $0.36 millions in the similar quarter a year before and sequentially Revenue Tumbled from $0.00 millions.

Acer Therapeutics Inc Customers

Acer Therapeutics Inc growth Rates, Profitability, PE

Revenues receded in single digits, at PRET amid the October to December 31 2022 time-frame

For the fourth quarter of 2022 PRET Losses have extended of $-7.81 per share compare to $-0.43 a year prior and EPS improved from $-14.52 per share from the previous quarter.

Revenues decreased by -5.307 % to $80.65 millions from $85.17 millions in the same quarter a year prior and sequentially Revenues advanced by 10.767 % from $72.81 millions.

Pennsylvania Real Estate Investment Trust stock quotes, charts, profile

Pennsylvania Real Estate Investment Trust advance Rates, Profitability, PE

For the fiscal span ending December 31 2022 company decreased a loss per share of $-0.23 per share compare to $-0.56 a year prior and Income per Share improved from $-0.44 per share from the prior reporting period.

Revenues remained unaffected to $0.00 millions from $1.00 millions in the corresponding reporting period a year prior and sequentially Revenues advanced from $0.00 millions.

Terns Pharmaceuticals Inc Customers

Terns Pharmaceuticals Inc Suppliers

For the financial time-frame closing December 31 2022 Gold Royalty Corp lost money of $-0.14 per share compare to $-0.14 a year before and from $0.00 per share from the prior reporting season.

Revenues remained unaltered by 0 % to $3.94 millions from $3.94 millions in the corresponding reporting season a year before and sequentially Revenues advanced from $0.00 millions.

Gold Royalty Corp Competitors, Market Share

Gold Royalty Corp rise Rates, Profitability, PE

Focusing on the most recent fiscal period PX bottom-line turned positive at $0.03 per share, relative to the results of $-3.47 per share a year prior quarter, In the previous quarter PX realized $0.05 per share.

P10 Inc Customers

P10 Inc Revenue growth Rates

The Railroads company disclosed that Revenues almost doubled, in the second quarter of 2022

For the April to June 30 2022 span company had turn a round to surplus by displaying Income per Share of $0.58 per share compare to $-0.13 a year before and income per share turned positive from $-1.11 per share from the previous reporting season.

Revenues inched up strongly by 52.021 % to $56.79 millions from $37.35 millions in the same reporting season a year before and sequentially Revenue Tumbled by -39.094 % from $93.24 millions.

Freightcar America Inc Suppliers

Freightcar America Inc improvement Rates, Profitability, PE

Reduction in profits despite of Increase in orders at the Abercrombie And Fitch Co amid the fourth quarter of 2022

ANF disclosed declining eps on increasing revenue in the Jan 28 2023 report, where Revenue grew by 3.312 % to $1.20 billions relative to $1.16 billions on a year-over-year basis, while earnings per share dropped by -29.1 % to $0.78 per share, income per share was $1.10 in fourth quarter of 2021.

Abercrombie And Fitch Co Competitors, Market Share

Abercrombie And Fitch Co Suppliers

In the Dec 31 2022 report FCCN reached zero gain at $0.00 per share, opposite of $0.00 per share a year before reporting period, In the previous reporting period The company realized $0.00 per share.

Spectral Capital Corporation Suppliers

Spectral Capital Corporation Revenue improvement Rates